vs

Side-by-side financial comparison of Cheche Group Inc. (CCG) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.

SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $32.8M, roughly 1.2× Cheche Group Inc.). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 0.5%, a 35.4% gap on every dollar of revenue.

Cheche Group Inc. is a leading automotive digital service provider headquartered in China. It offers integrated solutions including auto insurance intermediary services, smart auto after-sales support, and connected vehicle technology products, serving individual car owners, auto dealerships, and insurance partners across domestic and select Southeast Asian markets.

SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.

CCG vs SBC — Head-to-Head

Bigger by revenue
SBC
SBC
1.2× larger
SBC
$39.6M
$32.8M
CCG
Higher net margin
SBC
SBC
35.4% more per $
SBC
35.9%
0.5%
CCG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCG
CCG
SBC
SBC
Revenue
$32.8M
$39.6M
Net Profit
$153.6K
$14.2M
Gross Margin
5.7%
73.1%
Operating Margin
32.5%
Net Margin
0.5%
35.9%
Revenue YoY
-10.9%
Net Profit YoY
117.2%
EPS (diluted)
$0.00
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCG
CCG
SBC
SBC
Q1 26
$32.8M
Q4 25
$39.6M
Q3 25
$43.4M
Q2 25
$26.0M
$43.4M
Q1 25
$47.3M
Q4 24
$18.6M
$44.4M
Q3 24
$53.1M
Q2 24
$36.1M
$53.1M
Net Profit
CCG
CCG
SBC
SBC
Q1 26
$153.6K
Q4 25
$14.2M
Q3 25
$12.8M
Q2 25
$-492.4K
$2.5M
Q1 25
$21.5M
Q4 24
$-196.7K
$6.5M
Q3 24
$2.8M
Q2 24
$-7.6M
$18.5M
Gross Margin
CCG
CCG
SBC
SBC
Q1 26
5.7%
Q4 25
73.1%
Q3 25
70.6%
Q2 25
4.9%
69.2%
Q1 25
79.7%
Q4 24
5.2%
76.3%
Q3 24
81.5%
Q2 24
4.3%
74.2%
Operating Margin
CCG
CCG
SBC
SBC
Q1 26
Q4 25
32.5%
Q3 25
36.6%
Q2 25
-2.0%
33.6%
Q1 25
51.1%
Q4 24
-0.3%
10.6%
Q3 24
26.1%
Q2 24
-4.7%
51.4%
Net Margin
CCG
CCG
SBC
SBC
Q1 26
0.5%
Q4 25
35.9%
Q3 25
29.6%
Q2 25
-1.9%
5.7%
Q1 25
45.4%
Q4 24
-1.1%
14.7%
Q3 24
5.3%
Q2 24
-21.0%
34.8%
EPS (diluted)
CCG
CCG
SBC
SBC
Q1 26
$0.00
Q4 25
$0.15
Q3 25
$0.12
Q2 25
$-0.01
$0.02
Q1 25
$0.21
Q4 24
$-0.00
$0.05
Q3 24
$0.03
Q2 24
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCG
CCG
SBC
SBC
Cash + ST InvestmentsLiquidity on hand
$20.0M
$164.1M
Total DebtLower is stronger
$193.3K
$42.8M
Stockholders' EquityBook value
$248.3M
Total Assets
$203.5M
$380.4M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCG
CCG
SBC
SBC
Q1 26
$20.0M
Q4 25
$164.1M
Q3 25
$127.4M
Q2 25
$23.1M
$152.7M
Q1 25
$132.1M
Q4 24
$21.1M
$125.0M
Q3 24
$137.4M
Q2 24
$28.2M
Total Debt
CCG
CCG
SBC
SBC
Q1 26
$193.3K
Q4 25
$42.8M
Q3 25
$21.1M
Q2 25
$690.0K
$7.1M
Q1 25
$6.9M
Q4 24
$6.6M
Q3 24
$823.2K
Q2 24
Stockholders' Equity
CCG
CCG
SBC
SBC
Q1 26
Q4 25
$248.3M
Q3 25
$248.0M
Q2 25
$47.1M
$244.6M
Q1 25
$226.4M
Q4 24
$49.1M
$195.1M
Q3 24
$205.0M
Q2 24
$48.6M
$8.8M
Total Assets
CCG
CCG
SBC
SBC
Q1 26
$203.5M
Q4 25
$380.4M
Q3 25
$321.4M
Q2 25
$177.3M
$315.3M
Q1 25
$284.6M
Q4 24
$177.7M
$266.1M
Q3 24
$296.5M
Q2 24
$139.3M
$19.5M
Debt / Equity
CCG
CCG
SBC
SBC
Q1 26
Q4 25
0.17×
Q3 25
0.09×
Q2 25
0.01×
0.03×
Q1 25
0.03×
Q4 24
0.03×
Q3 24
0.00×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCG
CCG
SBC
SBC
Operating Cash FlowLast quarter
$52.0M
Free Cash FlowOCF − Capex
$51.2M
FCF MarginFCF / Revenue
129.3%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
3.66×
TTM Free Cash FlowTrailing 4 quarters
$23.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCG
CCG
SBC
SBC
Q1 26
Q4 25
$52.0M
Q3 25
$-20.9M
Q2 25
$-44.7M
$-8.3M
Q1 25
$1.9M
Q4 24
$-15.8M
$-7.3M
Q3 24
$5.0M
Q2 24
$-1.0K
$19.2M
Free Cash Flow
CCG
CCG
SBC
SBC
Q1 26
Q4 25
$51.2M
Q3 25
$-20.9M
Q2 25
$-8.6M
Q1 25
$1.7M
Q4 24
$-16.0M
$-7.9M
Q3 24
$4.6M
Q2 24
$-1.1K
$18.3M
FCF Margin
CCG
CCG
SBC
SBC
Q1 26
Q4 25
129.3%
Q3 25
-48.3%
Q2 25
-19.9%
Q1 25
3.5%
Q4 24
-85.9%
-17.8%
Q3 24
8.7%
Q2 24
-0.0%
34.5%
Capex Intensity
CCG
CCG
SBC
SBC
Q1 26
Q4 25
2.0%
Q3 25
0.1%
Q2 25
0.7%
Q1 25
0.5%
Q4 24
1.2%
1.3%
Q3 24
0.8%
Q2 24
0.0%
1.6%
Cash Conversion
CCG
CCG
SBC
SBC
Q1 26
Q4 25
3.66×
Q3 25
-1.63×
Q2 25
-3.39×
Q1 25
0.09×
Q4 24
-1.12×
Q3 24
1.77×
Q2 24
1.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCG
CCG

Segment breakdown not available.

SBC
SBC

Franchising$10.3M26%
Medical Corporation Shobikai$8.1M21%
Medical Corporation Nasukai$7.2M18%
Management Services$6.3M16%
Rental Services$4.3M11%
Medical Corporation Association Furinkai$3.0M8%
Japan Medical And Beauty Inc$656.5K2%

Related Comparisons